INVESTINGAbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: ReportBy Scott Van VoorhisNov 12, 2019 10:00 AM EST
PRESS RELEASESAllergan Teams Up With Super Bowl MVP Von Miller To Raise Awareness Of Glaucoma's Impact On Daily LivingBy PR NewswireJan 16, 2020 7:30 AM EST
INVESTINGAbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: ReportBy Scott Van VoorhisNov 12, 2019 10:00 AM EST
EARNINGSAllergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie TakeoverBy Martin BaccardaxNov 5, 2019 9:40 AM EST
MARKETSDow Futures, Uber, Shake Shack and China Trade - 5 Things You Must Know TuesdayBy Joseph WoelfelNov 5, 2019 6:17 AM EST
INVESTINGAbbVie Posts Stronger-Than-Expected Earnings, Lifts ForecastBy M. Corey GoldmanNov 1, 2019 9:35 AM EDT
STOCKSEndo, Opioid Producers Said to Mull Unusual Lawsuit Settlement; Shares RiseBy Rob DanielOct 1, 2019 10:33 AM EDT
MARKETSBroadcom, WeWork, Dow Futures, China Trade, Cloudflare - 5 Things You Must KnowBy Joseph WoelfelSep 13, 2019 6:37 AM EDT
STOCKSMallinckrodt Plunges on Report It's Considering Filing for BankruptcyBy M. Corey GoldmanSep 5, 2019 9:33 AM EDT
INVESTINGAllergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid LitigationBy M. Corey GoldmanAug 30, 2019 9:39 AM EDT
INVESTINGEndo Surges as Opioid Maker Reaches Settlement in Landmark LawsuitBy Scott Van VoorhisAug 20, 2019 10:43 AM EDT
INVESTINGEndo, Allergan Said Nearing Deals to Limit Ohio Litigation Over OpioidsBy Simon ConstableAug 20, 2019 7:23 AM EDT
MARKETSDow Finished Up 300 Points, Rebound From Worst Day of the YearBy Rob LenihanAug 6, 2019 4:37 PM EDT
EARNINGSAllergan Tops Q2 Profit Estimate, Lifts 2019 Revenue Guidance After Abbive DealBy Martin BaccardaxAug 6, 2019 9:37 AM EDT
MARKETSDow Rebound?, Disney Reports, Barneys Files Chapter 11 - 5 Things You Must KnowBy Joseph WoelfelAug 6, 2019 5:52 AM EDT
VideoTrump Just Deepened the Tariff War -- Retail Investors Were the Smart OnesAug 1, 2019 4:25 PM EDT
